Risk Factors of Haemorrhagic Transformation for Acute Ischaemic Stroke in Chinese Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator: A Systematic Review and Meta-Analysis

Stroke and Vascular Neurology - United Kingdom
doi 10.1136/svn-2018-000141
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Diagnostic Accuracy of Computed Tomography Perfusion in the Prediction of Haemorrhagic Transformation and Patient Outcome in Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis

European Stroke Journal
NeurologyCardiovascular MedicineCardiology
2019English

Systemic Review : Role of Tissue Plasminogen Activator for Acute Ischemic Stroke

The Egyptian Journal of Hospital Medicine
2018English

Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry

PLoS ONE
Multidisciplinary
2014English

Pharmacotherapy Updates of Recombinant Tissue Plasminogen Activator (R-Tpa) in Acute Ischemic Stroke

Jentashapir Journal of Health Research
2016English

Low-Dose Versus Standard-Dose Tissue Plasminogen Activator for Intravenous Thrombolysis in Asian Acute Ischemic Stroke Patients

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Intravenous Thrombolysis in Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis to Aid Decision Making in Patients Over 80 Years of Age

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2011English

Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2006English

Phosphorylated Recombinant HSP27 Protects the Brain and Attenuates Blood-Brain Barrier Disruption Following Stroke in Mice Receiving Intravenous Tissue-Plasminogen Activator

PLoS ONE
Multidisciplinary
2018English

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke Can Cause Inferior Myocardial Infarction?

Neurology International
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy